Niklason Laura E

CIK 00018780751 companyDURHAM, NC

SEC Profile

Transactions

Companies

Filings

CIK

0001878075

Recent Transactions

50 trades

Award
Humacyte, Inc.$HUMA
Stock Options (right to buy)
2025-11-16+311,100→ 311,100 total
Sale
Humacyte, Inc.$HUMA
Common Stock
2025-08-20$1.58/sh−591,685→ 0 total
Sale
Humacyte, Inc.$HUMA
Common Stock
2025-08-19$1.63/sh−1,100,000→ 591,685 total
Sale
Humacyte, Inc.$HUMA
Common Stock
2025-08-18$1.83/sh−549,360→ 1,691,685 total
Award
Humacyte, Inc.$HUMA
Stock Options (right to buy)
2025-06-12+0→ 0 total
Award
Humacyte, Inc.$HUMA
Stock Options (right to buy)
2025-01-21+1,130,311→ 1,130,311 total
Award
Humacyte, Inc.$HUMA
Stock Options (right to buy)
2024-12-19+525→ 2,625 total
Sale
Humacyte, Inc.$HUMA
Common Stock
2024-11-20$4.40/sh−261,369→ 1,730,884 total
Sale
Humacyte, Inc.$HUMA
Common Stock
2024-11-19$4.34/sh−427,459→ 1,992,253 total
Purchase
Humacyte, Inc.$HUMA
Common Stock
2024-11-19$4.44/sh+1,797→ 243,851 total
Sale
Humacyte, Inc.$HUMA
Common Stock
2024-11-18$4.44/sh−811,172→ 2,419,712 total
Sale
Humacyte, Inc.$HUMA
Common Stock
2024-09-10$5.23/sh−288,674→ 3,230,884 total
Sale
Humacyte, Inc.$HUMA
Common Stock
2024-09-09$5.42/sh−157,704→ 3,519,558 total
Sale
Humacyte, Inc.$HUMA
Common Stock
2024-08-29$6.35/sh−352,112→ 3,677,262 total
Purchase
Humacyte, Inc.$HUMA
Common Stock
2024-08-29$6.54/sh+1,222→ 242,054 total
Sale
Humacyte, Inc.$HUMA
Common Stock
2024-08-28$6.47/sh−277,090→ 4,029,374 total
Sale
Humacyte, Inc.$HUMA
Common Stock
2024-08-27$6.71/sh−252,676→ 4,306,464 total
Award
Humacyte, Inc.$HUMA
Stock Options (right to buy)
2024-06-13+50,000→ 50,000 total
Sale
Humacyte, Inc.$HUMA
Common Stock
2024-06-12$7.30/sh−271,518→ 4,559,140 total
Sale
Humacyte, Inc.$HUMA
Common Stock
2024-06-11$7.09/sh−282,000→ 4,907,288 total
Sale
Humacyte, Inc.$HUMA
Common Stock
2024-06-11$7.02/sh−76,630→ 4,830,658 total
Sale
Humacyte, Inc.$HUMA
Common Stock
2024-06-04$7.28/sh−1,852→ 5,189,288 total
Purchase
Humacyte, Inc.$HUMA
Common Stock
2024-06-04$6.35/sh+2,362→ 240,832 total
Purchase
Humacyte, Inc.$HUMA
Common Stock
2024-06-03$7.37/sh+2,050→ 238,470 total
Sale
Humacyte, Inc.$HUMA
Common Stock
2024-06-03$7.42/sh−190,214→ 5,191,140 total
Sale
Humacyte, Inc.$HUMA
Common Stock
2024-05-31$7.78/sh−716,573→ 5,474,567 total
Sale
Humacyte, Inc.$HUMA
Common Stock
2024-05-31$8.93/sh−93,213→ 5,381,354 total
Award
Humacyte, Inc.$HUMA
Stock Options (right to buy)
2023-12-11+525→ 2,100 total
Award
Humacyte, Inc.$HUMA
Stock Options (right to buy)
2023-12-08+803,000→ 803,000 total
Exercise/Conversion
Humacyte, Inc.$HUMA
Stock Options (right to buy)
2023-10-10−114,420→ 48,176 total
Exercise/Conversion
Humacyte, Inc.$HUMA
Common Stock
2023-10-10$1.19/sh+114,420→ 1,384,660 total
Sale
Humacyte, Inc.$HUMA
Common Stock
2023-09-14$2.78/sh−2,000,000→ 6,191,140 total
Sale
Humacyte, Inc.$HUMA
Common Stock
2023-08-21$3.39/sh−602,443→ 8,191,140 total
Sale
Humacyte, Inc.$HUMA
Common Stock
2023-08-18$3.57/sh−626,979→ 8,793,583 total
Sale
Humacyte, Inc.$HUMA
Common Stock
2023-08-17$3.68/sh−570,174→ 9,420,562 total
Award
Humacyte, Inc.$HUMA
Stock Options (right to buy)
2023-06-15+8,500→ 8,500 total
Sale
Humacyte, Inc.$HUMA
Common Stock
2023-06-15$3.12/sh−500,000→ 9,990,736 total
Sale
Humacyte, Inc.$HUMA
Common Stock
2023-06-13$2.60/sh−4,875,000→ 10,490,736 total
Sale
Humacyte, Inc.$HUMA
Common Stock
2023-05-25$2.75/sh−2,625,000→ 15,365,736 total
Exercise/Conversion
Humacyte, Inc.$HUMA
Stock Options (right to buy)
2023-03-01−100,000→ 162,596 total
Exercise/Conversion
Humacyte, Inc.$HUMA
Common Stock
2023-03-01$1.19/sh+100,000→ 1,270,240 total
Sale
Humacyte, Inc.$HUMA
Common Stock
2022-12-16$2.53/sh−239,538→ 17,990,736 total
Sale
Humacyte, Inc.$HUMA
Common Stock
2022-12-15$2.63/sh−93,426→ 18,230,274 total
Purchase
Humacyte, Inc.$HUMA
Common Stock
2022-12-15$2.54/sh+10,000→ 1,170,240 total
Sale
Humacyte, Inc.$HUMA
Common Stock
2022-12-14$2.76/sh−276,304→ 18,323,700 total
Sale
Humacyte, Inc.$HUMA
Common Stock
2022-12-13$2.84/sh−330,000→ 18,600,004 total
Award
Humacyte, Inc.$HUMA
Stock Options (right to buy)
2022-12-08+444,500→ 444,500 total
Sale
Humacyte, Inc.$HUMA
Common Stock
2022-09-15$4.00/sh−1,522,500→ 18,930,004 total
Purchase
Humacyte, Inc.$HUMA
Common Stock
2022-09-15$4.14/sh+2,000→ 1,160,240 total
Award
Humacyte, Inc.$HUMA
Stock Options (right to buy)
2022-06-09+8,500→ 8,500 total

Companies

Humacyte, Inc.
Director, President, CEO and Director
$HUMA

Recent Filings

Address

2525 EAST NORTH CAROLINA HIGHWAY 54

DURHAM, NC, 27713

View on SEC.gov